BridgeMD
Tests treatment safety and results for Adhesive Capsulitis of the Shoulder
Official title Dose Efficacy in Adhesive Capsulitis
ClinicalTrials.gov ID: NCT06848374
What this study is testing
What is 40 mg Methylprednisolone?
40 mg Methylprednisolone is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for adhesive capsulitis of the shoulder.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to find out if the treatment of adhesive capsulitis with 40 mg of methylprednisolone in combination with a hydrodilatation is comparable to 80 mg of methylprednisolone for pain reduction, improving shoulder mobility, and reducing side effects. Researchers will enroll 40 people in this study which is taking place solely at the Toronto Rehabilitation Institute, University Avenue.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- \>18 years of age
- Diagnostic of adhesive capsulitis of the shoulder
You likely can't join if
- Injection received in the affected shoulder \< 3 months ago (any kind)
- History of previous surgery in the affected shoulder
- Glenohumeral osteoarthritis more than mild on the xray
- Pregnancy
- Blood thinner (other than Aspirin 80 mg) or bleeding disorder
- Active infection (requiring antibiotic)
See the full eligibility criteria
- \>18 years of age
- Diagnostic of adhesive capsulitis of the shoulder
- Injection received in the affected shoulder \< 3 months ago (any kind)
- History of previous surgery in the affected shoulder
- Glenohumeral osteoarthritis more than mild on the xray
- Pregnancy
- Blood thinner (other than Aspirin 80 mg) or bleeding disorder
- Active infection (requiring antibiotic)
- Allergy to steroid or lidocaine
- Cognitive impairment
- Active litigation
- Inflammatory connective tissue disorder
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.